HealthEquity Income Statement

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Revenue	1,291	1,200	999.59	861.75	756.56	733.57
Revenue Growth (YoY)	12.20%	20.03%	16.00%	13.90%	3.13%	37.89%
Cost of Revenue	416.65	422.52	376.95	369.81	331.79	318.24
Gross Profit	874.01	777.26	622.64	491.94	424.77	415.33
Selling, General & Admin	209.78	223	182.93	166.32	144.04	134.46
Depreciation & Amortization Expenses	108.01	111.88	92.76	94.59	82.79	76.06
Research & Development	256.81	239.51	218.81	193.38	157.36	124.81
Other Operating Expenses	5.88	40.54	10.44	28.6	64.81	45.99
Total Operating Expenses	580.48	614.93	504.94	482.88	449	381.32
Operating Income	293.54	162.33	117.7	9.06	-24.24	34.01
Interest Expense	-59.12	-60.63	-55.46	-48.42	-36.57	-34.88
Other Non-Operating Income (Expense)	12.08	14.33	12.8	1.27	-5.93	5.01
Total Non-Operating Income (Expense)	-47.04	-46.3	-42.66	-47.15	-42.5	-29.87
Pretax Income	246.49	116.03	75.04	-38.1	-66.74	4.14
Provision for Income Taxes	54.67	19.33	19.33	-11.95	-22.45	-4.69
Net Income	191.83	96.7	55.71	-26.14	-44.29	8.83
Net Income to Common	191.83	96.7	55.71	-26.14	-44.29	8.83
Net Income Growth	98.37%	73.58%	-	-	-	-77.73%
Shares Outstanding (Basic)	86	87	86	84	83	74
Shares Outstanding (Diluted)	88	89	87	84	83	76
Shares Change (YoY)	-0.37%	2.15%	2.98%	1.57%	9.85%	10.56%
EPS (Basic)	2.21	1.11	0.65	-0.31	-0.53	0.12
EPS (Diluted)	2.18	1.09	0.64	-0.31	-0.53	0.12
EPS Growth	100.00%	70.31%	-	-	-	-79.31%
Free Cash Flow	412.96	337.77	241.13	147.28	132.09	168.53
Free Cash Flow Growth	22.26%	40.08%	63.73%	11.50%	-21.62%	72.45%
Free Cash Flow Per Share	4.70	3.80	2.77	1.74	1.59	2.23
Gross Margin	67.72%	64.78%	62.29%	57.09%	56.14%	56.62%
Operating Margin	22.74%	13.53%	11.77%	1.05%	-3.20%	4.64%
Profit Margin	14.86%	8.06%	5.57%	-3.03%	-5.85%	1.20%
FCF Margin	32.00%	28.15%	24.12%	17.09%	17.46%	22.97%
EBITDA	448.69	324.79	270.78	170.26	112.95	149.92
EBITDA Margin	34.76%	27.07%	27.09%	19.76%	14.93%	20.44%
EBIT	293.54	162.33	117.7	9.06	-24.24	34.01
EBIT Margin	22.74%	13.53%	11.77%	1.05%	-3.20%	4.64%
Effective Tax Rate	22.18%	16.66%	25.76%	31.38%	33.64%	-113.38%

Updated Oct 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q